Overview

When fully realized as a comparative science, genomics offers spectacular rewards to life science and the world. Driven by plummeting costs and increasing quality of sequencing, the growing array of public studies, the continuation of Moore’s law for computing, and an ever-richer understanding of the underlying science, comparative genomics is fast becoming a reality.

In healthcare, genomic studies combined with individual testing enables us to determine a patient’s susceptibility to disease, precisely diagnose their disorders, predict how they will respond to a particular drug, and match them with the right therapeutics. Personalized medicine has the potential to eliminate unnecessary treatments, reduce the incidence of adverse reactions, increase drug efficacy, and, ultimately, improve patient outcomes and reduce system costs.

In agriculture, genomics is becoming critical to biological research. Large-scale comparative genomics empowers researchers to pinpoint genes and variants that increase plant yield, broaden biodiversity, and reduce environmental impact — in short, better feed the world.

GenomeQuest serves major pharma, biotech firms, global agriculture companies, research hospitals, IP legal groups, diagnostic companies, and universities around the world. With leadership in genomic technology, know-how, and vision, the company is focused on helping these organizations realize the promise of genomics.